US 12,270,978 B2
Devices, systems, and methods for otology
Eugene de Juan, Brisbane, CA (US); Signe Erickson, Brisbane, CA (US); Charles Limb, Brisbane, CA (US); and Vrad Levering, Brisbane, CA (US)
Assigned to Spiral Therapeutics Inc., Brisbane, CA (US)
Filed by Spiral Therapeutics Inc., Brisbane, CA (US)
Filed on Jan. 22, 2021, as Appl. No. 17/155,575.
Claims priority of provisional application 63/082,996, filed on Sep. 24, 2020.
Claims priority of provisional application 63/081,015, filed on Sep. 21, 2020.
Claims priority of provisional application 63/080,510, filed on Sep. 18, 2020.
Claims priority of provisional application 63/078,141, filed on Sep. 14, 2020.
Claims priority of provisional application 63/077,448, filed on Sep. 11, 2020.
Claims priority of provisional application 63/051,568, filed on Jul. 14, 2020.
Claims priority of provisional application 63/040,495, filed on Jun. 17, 2020.
Claims priority of provisional application 63/024,183, filed on May 13, 2020.
Claims priority of provisional application 62/965,481, filed on Jan. 24, 2020.
Prior Publication US 2021/0228411 A1, Jul. 29, 2021
Int. Cl. A61F 11/00 (2022.01); A61B 1/018 (2006.01); A61B 1/227 (2006.01); A61B 17/29 (2006.01); A61B 17/32 (2006.01); A61B 17/3205 (2006.01); A61B 17/34 (2006.01); A61B 18/04 (2006.01); A61B 18/14 (2006.01); A61B 18/20 (2006.01); A61F 2/958 (2013.01); A61F 11/20 (2022.01); A61M 31/00 (2006.01); A61M 37/00 (2006.01); G02B 21/00 (2006.01); G02B 21/22 (2006.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61F 2/18 (2006.01)
CPC G02B 21/0012 (2013.01) [A61B 1/018 (2013.01); A61B 1/227 (2013.01); A61B 17/29 (2013.01); A61B 17/320068 (2013.01); A61B 17/3205 (2013.01); A61B 17/3423 (2013.01); A61B 17/3468 (2013.01); A61B 17/3478 (2013.01); A61B 18/04 (2013.01); A61B 18/1485 (2013.01); A61B 18/20 (2013.01); A61F 2/958 (2013.01); A61F 11/20 (2022.01); A61F 11/202 (2022.01); A61M 31/00 (2013.01); A61M 31/002 (2013.01); A61M 37/0015 (2013.01); G02B 21/0032 (2013.01); G02B 21/22 (2013.01); A61B 2017/00115 (2013.01); A61B 2017/00787 (2013.01); A61B 2017/00867 (2013.01); A61B 2017/32007 (2017.08); A61B 2018/00327 (2013.01); A61B 2217/005 (2013.01); A61F 2002/183 (2013.01); A61F 2250/0067 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0046 (2013.01); A61M 2205/04 (2013.01); A61M 2210/0662 (2013.01); A61M 2210/0668 (2013.01)] 17 Claims
OG exemplary drawing
 
1. A method of treating a middle ear or inner ear disorder of a patient, the method comprising:
implanting a port device in an annulus tympanicus, and
accessing the middle ear of the patient by advancing a distal end portion of an otologic instrument through or adjacent to the annulus tympanicus of the patient, wherein the advancing the distal end portion of the otologic instrument through or adjacent to the annulus tympanicus is performed by passing the distal end portion of the otologic instrument through a passage defined by the port device.